Ph.D. Candidate
Biomedical Engineering · China · 2025-01-09
Proposed Endeavor
The petitioner proposes to continue conducting research and developing novel strategies and therapies to target various diseases, including cancer, autoimmune diseases, and infectious diseases, to enhance biotechnology for cancer therapy and vaccine development.
Framework Evaluation
3 of 3 criteria metThe research addresses critical national needs in public health, specifically cancer treatment affecting 2 million Americans, and aligns with national technology priorities.
The petitioner has an extensive record of 1,956 citations, 10 publications, 2 patents, and has been involved in projects funded by major agencies like NIH, DARPA, and DOD.
Given the petitioner's specialized expertise in biomedical engineering and the urgency of the public health challenges addressed, waiving the labor certification is in the national interest.
Why This Petition Was Approved
Request for Evidence (RFE)
Successfully AddressedA Request for Evidence was issued, and the firm provided a thorough response that resulted in the final approval.
Evidence
Similar Cases
Scientist
Biotechnology · Dominican Republic
Research Scientist
Biotechnology · Greece
Clinical Researcher
Biotechnology
Associate Professor
Biotechnology · Sudan
Frequently Asked Questions
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-09.
Browse all casesAt a Glance
EB-2 (NIW) Case Data
Scraped Case Data
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist